
Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome
Author(s) -
Edinson Dante Meregildo-Rodríguez,
Victor Hugo BardalesZuta
Publication year - 2021
Publication title -
le infezioni in medicina
Language(s) - English
Resource type - Journals
eISSN - 2532-8689
pISSN - 1124-9390
DOI - 10.53854/liim-2904-13
Subject(s) - plasmapheresis , medicine , guillain barre syndrome , modified rankin scale , retrospective cohort study , pediatrics , logistic regression , mortality rate , antibody , surgery , immunology , ischemic stroke , ischemia
To compare the clinical results (28-day mortality and disability at discharge) in patients with Guillain-Barré Syndrome (GBS) treated with immunoglobulin or plasmapheresis at the Regional Lambayeque in Peru Hospital.